Alkermes Plc
NASDAQ:ALKS
Alkermes Plc
NASDAQ:ALKS
Price:
35.36
USD
17.28%
Market Closed
Market Cap:
$5.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Alkermes Plc
NASDAQ:ALKS
|
IE |
|
Digital Bros SpA
MIL:DIB
|
IT |
|
Global Capital Markets Ltd
BSE:530263
|
IN |
|
Genus Prime Infra Ltd
BSE:532425
|
IN |
|
B
|
Black Pearl SA
WSE:BPC
|
PL |
|
M
|
musicMagpie PLC
LSE:MMAG
|
UK |
|
Vision Marine Technologies Inc
NASDAQ:VMAR
|
CA |
|
Cardinal Energy Ltd (Alberta)
F:C0Y
|
CA |
|
N
|
Novus Holdings Ltd
JSE:NVS
|
ZA |
|
H
|
Hapag Lloyd AG
F:HLAG
|
DE |
|
Ark Restaurants Corp
NASDAQ:ARKR
|
US |
Multiples-Based Value
The Multiples-Based Value of one
ALKS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 35.36 USD,
Alkermes Plc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALKS Multiples-Based Value
LOCKED
Multiples Across Competitors
ALKS Competitors Multiples
Alkermes Plc Competitors
Alkermes Plc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IE |
|
Alkermes Plc
NASDAQ:ALKS
|
5.9B USD | 4 | 24.2 | 18.9 | 21 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.5B USD | 6.3 | 91.9 | 15.2 | 21.1 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
361.6B USD | 111.3 | -1 738.3 | 16 147.7 | -1 823.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.6B USD | 5.2 | 24.6 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173B USD | 5.9 | 20.3 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.4B USD | 9.5 | 28.7 | 21.6 | 22.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.7B USD | 5.7 | 18.1 | 13.6 | 15.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.1 | 34.7 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
